Get it on Google Play

BioCardia enrolls first patient at University of Wisconsin in phase 3 trial

October 30, 2025 8:01 AM EDT Send to a Friend
BioCardia Inc. (NASDAQ: BCDA) announced that the University of Wisconsin School of Medicine and Public Health has enrolled its first ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login